167 Results

People

  1. Lee
    Lee
  2. Wong
    Wong
  3. Shaha
    Shaha
  4. Kraus
    Kraus
  5. Wolden
    Wolden
  6. Pfister
    Pfister
  7. Riaz
    Riaz
  8. Shah
    Shah
  9. Ilson
    Ilson
  10. Sherman
    Sherman

Groups

  1. Department of Medicine (75)
  2. Solid Tumor Oncology Division (55)
  3. Surgery (53)
  4. Survivorship Research (51)
  5. Radiation Oncology, Department of (49)
  6. Center for Pancreatic Cancer Research (29)
  7. Head and Neck Service (26)
  8. Division of Subspecialty Medicine (23)
  9. Center for Hematologic Malignancies (18)
  10. Gastrointestinal Oncology Service (14)
  1. "dysphagia"
Formats
  1. Journal Article (156)
  2. Review (9)
  3. Book Section (1)
  4. Editorial (1)
Groups
  1. Department of Medicine (75)
  2. Solid Tumor Oncology Division (55)
  3. Surgery (53)
  4. Survivorship Research (51)
  5. Radiation Oncology, Department of (49)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Nancy Lee (35)
  2. Richard Wong (19)
  3. Ashok Shaha (16)
  4. Dennis Kraus (15)
  5. Eric Sherman (15)
  6. David Pfister (14)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (9)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (12)

More Years

Publications
  1. Head & Neck (10)
  2. Journal of Clinical Oncology (10)
  3. International Journal of Radiation Oncology, Biology, Physics (8)
  4. Cancer (6)
  5. Lancet Oncology (6)
  6. Annals of Thoracic Surgery (4)

More Publications

Publishers
  1. Elsevier Inc. (29)
  2. Elsevier Science, Inc. (15)
  3. Wiley Blackwell (15)
  4. Springer (13)
  5. American Society of Clinical Oncology (10)
  6. John Wiley & Sons, Inc. (10)

More Publishers

Results (167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erdheim-Chester disease masquerading as CLIPPERS
    Journal Article

    Alkabie, S.; Diamond, E. L.
    Neurology: Neuroimmunology & Neuroinflammation (2024)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
    Journal Article

    Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffmann, M. S.; Coombs, C. C.; Lamanna, N.; Ma, S.; Jagadeesh, D.; Munir, T.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • A randomized, multi-center, open label study to compare the safety and efficacy between afatinib monotherapy and combination therapy with HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
    Journal Article

    Kwag, E.; Kim, S. D.; Shin, S. H.; Oak, C.; Park, S. J.; Choi, J. Y.; Hoon Yoon, S.; Kang, I. C.; Jeong, M. K.; Woo Lee, H.; more...
    Integrative Cancer Therapies (2024)

    Fulltext@MSK | Save
  • Association of acute incidental cerebral microinfarcts with subsequent ischemic stroke in patients with cancer
    Journal Article

    Naftali, J.; Barnea, R.; Leader, A.; Eliahou, R.; Pardo, K.; Tolkovsky, A.; Hasminski, V.; Raphaeli, G.; Bloch, S.; Shochat, T.; more...
    Neurology (2024)

    Fulltext@MSK | Save
  • Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma
    Journal Article

    Ryu Tiger, Y. K.; Jain, S.; Barta, S. K.; Tolu, S.; Estrella, B.; Sawas, A.; Lue, J. K.; Francescone, M. M.; Pro, B.; Amengual, J. E.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Advances in diagnostic, staging, and restaging evaluation of esophageal and gastric cancer
    Review

    Nobel, T.; Sihag, S.
    Surgical Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Reirradiation with proton therapy for recurrent malignancies of the esophagus and gastroesophageal junction: Results of the proton collaborative group multi-institutional prospective registry trial
    Journal Article

    Hotca, A.; Sindhu, K. K.; Lehrer, E. J.; Hartsell, W. F.; Vargas, C.; Tsai, H. K.; Chang, J. H.; Apisarnthanarax, S.; Nichols, R. C. Jr; Chhabra, A. M.; more...
    Advances in Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Management of symptoms and treatment-related toxicities of head and neck cancers
    Book Section

    Heal, C.; Han, J.; Koroulakis, A.; Yi, S. K.; Robbins, J. R.
    In Vapiwala, N.; Jones, J. A.; Vapiwala, K. V. (Eds.) Palliative Radiation Oncology (2024)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • ILUSTRO: Phase II multicohort trial of zolbetuximab in patients with advanced or metastatic claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma
    Journal Article

    Klempner, S. J.; Lee, K. W.; Shitara, K.; Metges, J. P.; Lonardi, S.; Ilson, D. H.; Fazio, N.; Kim, T. Y.; Bai, L. Y.; Moran, D.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save